45,346,873CHINA SHENGHUO PHARMACEUTICAL HOLDINGS, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF OPERATIONSAND COMPREHENSIVE INCOME (LOSS)(Amounts in USD, except shares)Years ended December 31,20112010Sales $
32,697,195Cost of goods sold16,980,00611,198,736Gross profit27,178,17621,498,459Operating expenses: Selling expenses19,838,58215,715,325 General and administrative expenses5,015,5343,638,445 Research and development expense710,361656,22525,564,47720,009,995Income from operations1,613,6991,488,464Other income (expenses): Interest income11,8108,325 Subsidy income536,013786,916 Interest expense(1,714,887)(842,560) Other income82,712247,536 Other expenses(409,405)(305,185)(1,493,757)(104,968)Income before income tax119,9421,383,496Income tax benefit (expense) 11,765(105,764)Net income before allocation to non-controlling interests131,7071,277,732Less: net (loss) income attributable to non-controlling interests(17,973)60,878Net income attributable to stockholders$149,680$1,216,854Comprehensive income:Net income 131,7071,277,732 Foreign currency translation adjustment187,15051,517Comprehensive income $318,857$1,329,249Comprehensive income attributable to non-controlling interests63,89363,333Comprehensive income attributable to stockholders254,9641,265,916Basic and diluted earnings per share$
0.06Weighted-average number of shares outstanding - basic and diluted19,679,40019,679,400CHINA SHENGHUO PHARMACEUTICAL HOLDINGS, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS(Amounts in USD)Years ended December 31,20112010Cash Flows from Operating Activities:Net income
1,277,732Adjustments to reconcile net income to net cash pro
|SOURCE China Shenghuo Pharmaceutical|
Copyright©2010 PR Newswire.
All rights reserved